Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3081)
All Articles published online
|
Jun 21, 2006 (publication date) through Feb 8, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ukai K, Ishigami M, Yoshioka K, Kawabe N, Katano Y, Hayashi K, Honda T, Yano M, Goto H. Mutations in carboxy-terminal part of E2 including PKR/eIF2α phosphorylation homology domain and interferon sensitivity determining region of nonstructural 5A of hepatitis C virus 1b: Their correlation with response to interferon monotherapy and viral load. World J Gastroenterol 2006; 12(23): 3722-3728 [PMID: 16773689 DOI: 10.3748/wjg.v12.i23.3722] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i23/3722.htm |
| Number | Citing Articles |
| 1 |
Scott A. Read, Mark W. Douglas. Advanced Therapy for Hepatitis C. 2011; : 12 doi: 10.1002/9781444346343.ch2
|
| 2 |
Federico Bolcic, Natalia Laufer, Carolina Torres, Lucila Cassino, Rita Reynoso, Jorge Quarleri. Longitudinal analysis of the 5′UTR, E2-PePHD and NS5A-PKRBD genomic regions of hepatitis C virus genotype 1a in association with the response to peginterferon and ribavirin therapy in HIV-coinfected patients. Antiviral Research 2012; 95(2): 72 doi: 10.1016/j.antiviral.2012.05.015
|
| 3 |
Alexander Tarr, Tanvi Khera, Kathrin Hueging, Julie Sheldon, Eike Steinmann, Thomas Pietschmann, Richard Brown. Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design. Viruses 2015; 7(7): 3995 doi: 10.3390/v7072809
|
| 4 |
M. F. Derbala, N. Z. El Dweik, S. R. Al Kaabi, A. D. Al‐Marri, F. Pasic, A. B. Bener, F. M. Shebl, A. M. Amer, M. T. Butt, R. Yakoob, A. John, M. Al Mohanadi, M. A. Al Khinji. Viral kinetic of HCV genotype‐4 during pegylated interferon alpha 2a: ribavirin therapy. Journal of Viral Hepatitis 2008; 15(8): 591 doi: 10.1111/j.1365-2893.2008.00988.x
|
| 5 |
Johannes G. Bode, Erwin D. Brenndörfer, Dieter Häussinger. Subversion of innate host antiviral strategies by the hepatitis C virus. Archives of Biochemistry and Biophysics 2007; 462(2): 254 doi: 10.1016/j.abb.2007.03.033
|
| 6 |
Saba Khaliq, Noreen Latief, Shah Jahan. Role of different regions of the hepatitis C virus genome in the therapeutic response to interferon-based treatment. Archives of Virology 2014; 159(1): 1 doi: 10.1007/s00705-013-1780-x
|
| 7 |
Kattareeya Kumthip, Niwat Maneekarn. The role of HCV proteins on treatment outcomes. Virology Journal 2015; 12(1) doi: 10.1186/s12985-015-0450-x
|
| 8 |
Iman Rad, Maryam Honardoost. Structural Modification in Hepatitis C Virus Envelope Protein; Potential Viral Strategy Against Interferon Therapy. International Journal of Peptide Research and Therapeutics 2020; 26(1): 171 doi: 10.1007/s10989-019-09826-2
|
| 9 |
Yanli Zeng, Wei Li, Jingtao Li, Junjie Wang, Bin Zhou, Jian Zhang, Shuwen Liu, Yingsong Wu, Jinlin Hou, Yuanping Zhou. Hepatitis C virus amino acid sequence diversity correlates with the outcome of combined interferon/ribavirin therapy in Chinese patients with chronic hepatitis C. Archives of Virology 2012; 157(6): 1113 doi: 10.1007/s00705-012-1283-1
|
| 10 |
Alicia Amadoz, Fernando Gonzáez-Candelas. A Novel Approach to Identify Candidate Prognostic Factors for Hepatitis C Treatment Response Integrating Clinical and Viral Genetic Data. Evolutionary Bioinformatics 2015; 11 doi: 10.4137/EBO.S20853
|
| 11 |
Fernanda de Mello Malta, José Eymard Moraes de Medeiros-Filho, Raymundo Soares de Azevedo, Luzia Gonçalves, Luiz Caetano da Silva, Flair José Carrilho, João Renato Rebello Pinho. Sequencing of E2 and NS5A regions of HCV genotype 3a in Brazilian patients with chronic hepatitis. Memórias do Instituto Oswaldo Cruz 2010; 105(1): 92 doi: 10.1590/S0074-02762010000100014
|
| 12 |
Ijaz Ali, Sanaullah Khan, Sobia Attaullah, Shahid Niaz Khan, Jabbar Khan, Sami Siraj, Aqib Iqbal, Zahoor A Swati, Muhammad Idrees. Response to combination therapy of HCV 3a infected Pakistani patients and the role of NS5A protein. Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-258
|
| 13 |
P. Muñoz de Rueda, J. Casado, R. Patón, D. Quintero, A. Palacios, A. Gila, R. Quiles, J. León, A. Ruiz-Extremera, J. Salmerón. Mutations in E2-PePHD, NS5A-PKRBD, NS5A-ISDR, and NS5A-V3 of Hepatitis C Virus Genotype 1 and Their Relationships to Pegylated Interferon-Ribavirin Treatment Responses. Journal of Virology 2008; 82(13): 6644 doi: 10.1128/JVI.02231-07
|
| 14 |
Shouichi Yokozaki, Yoshiaki Katano, Kazuhiko Hayashi, Masatoshi Ishigami, Akihiro Itoh, Yoshiki Hirooka, Isao Nakano, Hidemi Goto. Mutations in two PKR‐binding domains in chronic hepatitis C of genotype 3a and correlation with viral loads and interferon responsiveness. Journal of Medical Virology 2011; 83(10): 1727 doi: 10.1002/jmv.21959
|
| 15 |
Kazuaki Chayama, C Nelson Hayes. Hepatitis C virus: How genetic variability affects pathobiology of disease. Journal of Gastroenterology and Hepatology 2011; 26(s1): 83 doi: 10.1111/j.1440-1746.2010.06550.x
|
| 16 |
F. Bolcic, M. Sede, F. Moretti, G. Westergaard, M. Vazquez, N. Laufer, J. Quarleri. Analysis of the PKR-eIF2alpha phosphorylation homology domain (PePHD) of hepatitis C virus genotype 1 in HIV-coinfected patients by ultra-deep pyrosequencing and its relationship to responses to pegylated interferon-ribavirin treatment. Archives of Virology 2012; 157(4): 703 doi: 10.1007/s00705-012-1230-1
|